Navigation Links
XTL Receives Staff Letter From NASDAQ
Date:8/28/2007

XTL may Transfer its ADR Listing to the NASDAQ Capital Market

NEW YORK, August 28 /PRNewswire-FirstCall/ -- XTL Biopharmaceuticals Ltd. (NASDAQ: XTLB; LSE: XTL; TASE: XTL), a biopharmaceutical company engaged in the acquisition, development and commercialization of therapeutics for the treatment of unmet medical needs, particularly neuropathic pain and hepatitis C, today announced the receipt on August 23, 2007, of a NASDAQ Staff Deficiency Letter indicating that, according to the Company's financial statements for the six months ended June 30, 2007, XTL no longer complies with the minimum $10 million shareholders' equity requirement for continued listing on The NASDAQ Global Market as set forth in Marketplace Rule 4450(a)(3).

The Company intends to respond to NASDAQ with information that may enable the Company to maintain its listing on The NASDAQ Global Market; however, if the Company's plan for compliance is not satisfactory, the Company has the option to transfer its ADR listing to the NASDAQ Capital Market, previously called the NASDAQ SmallCap Market.

The NASDAQ Capital Market is a continuous trading market that operates in the same manner as The NASDAQ Global Market. The NASDAQ Capital Market is not related to, nor does it operate similarly to the over-the-counter markets including the OTCBB and Pink Sheets. Should the Company transfer its ADR listing to The NASDAQ Capital Market, its trading symbol on NASDAQ would remain "XTLB," and the Company does not expect any interruption in the trading of its ADRs.

The NASDAQ Capital Market includes over 500 issuers of a wide range of capitalization sizes. A NASDAQ Capital Market security satisfies all applicable qualification requirements for
'/>"/>

SOURCE XTL Biopharmaceuticals Ltd
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Medical College receives $377K to study brain disease
2. Lucigen receives $750K grant to boost biofuel yields
3. Medical College receives $1.4M cancer grant
4. Wisconsin biotech firm receives $107K NIH grant
5. InvivoSciences receives NIH grant for heart technology
6. Medical College receives $11 million grant to study high blood pressure
7. Madison business receives $115,000 of new state biofuels funding
8. Superior receives funds for technical training
9. UWM receives state funding for plastics research
10. GEs Centricity EHR receives federal certification
11. WHIE receives state eHealth Initiative contract

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/23/2009)... a provocative new study, a University of Utah sci... the major cause of global warming cannot be sta...ciety builds the equivalent of one new nuclear pow...ere will be any substantial near-term departure fr...e emission rates," says the new paper by Tim Garre...
(Date:11/23/2009)...ast communication, computation and more powerful w...o use quantum states as carriers of information is...s have shown, mathematically, how to gently tease ... keeping the information intact. Their work is rep...ters and highlighted with a Viewpoint in Physics...
(Date:11/23/2009)...RNewswire-FirstCall/--PDLBioPharma,Inc.(PDL)(Nasda...ember27,2009astheex-dividenddateforits$200millions...tizationtransactioncompletedonNovember2,2009.Thedi...ofrecordontherecorddate,December1,2009.NASDAQhasse...ershareofcommonstockforpurposesoftheex-dividenddat...
(Date:11/23/2009)...ire-FirstCall/--NeogenCorporation(Nasdaq: NEOG )an...oNeogen,sBoardofDirectorsatthecompany,srecentannua...yearsofexperienceinthefood,agriculture,andtradeind...iculturaleconomicsatVirginiaTechUniversity.FromJan...riculturenegotiatorwiththerankofambassador. ,, ...
Breaking Biology Technology:Is global warming unstoppable? 2Is global warming unstoppable? 3Is global warming unstoppable? 4PDL BioPharma Announces Ex-Dividend Date of November 27 for Special Dividend 2Richard T. Crowder Joins Neogen's Board of Directors 2
...,Bulletin Board: GOVX), an Atlanta-based biotechno...financial results and provided an,operational upda... Results for the Quarter Ended June 30, 2007 The ...three months,ended June 30, 2007, compared to net ...r the six months ended June 30, 2007, the Company,...
...ctors,meeting held today, the Directors declared a...ividend is payable on September 14, 2007 to,shareh...Aldrich: Sigma-Aldrich is a leading Life Science a...ganic chemical products and kits,are used in scien...eutical,development, the diagnosis of disease and ...
... for a lot of,folks. But for the one-in-five with ...e could also mean aggravating their sensitive stom..."Recipes for IBS," has more on,what people with IB...rom,ruining their celebrations. Listen to this re...//media.medialink.com/WebNR.aspx?story=33704 Reg...
Other Biology Technology:GeoVax Labs, Inc. Second Quarter Financial Results and Operational Update 2GeoVax Labs, Inc. Second Quarter Financial Results and Operational Update 3GeoVax Labs, Inc. Second Quarter Financial Results and Operational Update 4GeoVax Labs, Inc. Second Quarter Financial Results and Operational Update 5GeoVax Labs, Inc. Second Quarter Financial Results and Operational Update 6
(Date:11/23/2009)...of day matters to forest trees dealing with drough... team led by Professor Malcolm Campbell, Universit...arch and colleagues in the department of cell and ...pitalizing on their previous work to decode the ge...d how poplar trees use their 45,000 genes to respo...
(Date:11/23/2009)...ants gathered this week for the seventh annual Nat.... This year,s topic, "Synthetic Biology," brought ...chers to explore the engineering, scientific, and ...nthetic biology. , Bonnie L. Bassler, professor ...his year,s conference chair, challenged the attend...
(Date:11/23/2009)..."incontrovertible evidence" that the volcanic supe...73,000 years ago deforested much of central India,...report. , The volcano ejected an estimated 800 c...g a crater (now the world,s largest volcanic lake)...e. Ash from the event has been found in India, the...
Breaking Biology News(10 mins):Time of day matters to thirsty trees, U of T researcher discovers 2Synthetic biology offers new opportunities for interdisciplinary collaboration 2Supervolcano eruption -- in Sumatra -- deforested India 73,000 years ago 2Put Defibrillators in High Traffic Spots Studies Urge 53126 1Put Defibrillators in High Traffic Spots Studies Urge 53126 2Developing gene therapy to fight blindness 53121 1Developing gene therapy to fight blindness 53121 2Research shows rates of severe childhood obesity have tripled 9417 1Research shows rates of severe childhood obesity have tripled 9417 2
...eveloping fetuses are extremely sensitive to radia...ing mothers in need of screening or treatment for ...c Institute have developed a new set of modeling t...ore effective radiation therapy and nuclear medici...tion is a doubled-edged sword: It holds the power ...
...vices Eastern Forest Environmental Threat Assessme...reats summary viewer, a tool that will provide ima... contact information, and brief descriptions about...C partnered with the University of North Carolina ...alysis Center (NEMAC) to develop the tool, which i...
...ng from chronic mental or physical disabilities sh... warn two researchers from Emory University. Lori ...havioral Biology Program, has teamed with Scott Li...y, to launch an educational campaign countering cl...-assisted therapy (DAT). , "Dolphin-assisted ther...
Other Biology News:Safer, more accurate radiation therapy for expecting mothers 2Safer, more accurate radiation therapy for expecting mothers 3Forest Service launches Web-based forest threats viewing tool 2Dolphin 'therapy' a dangerous fad, Emory researchers warn 2Dolphin 'therapy' a dangerous fad, Emory researchers warn 3
Lyophilization Stabilizer from GenScript Corporation
...gital shaking water bath, with a comprehensive arr... water baths with seamless, splash-water protected... MULTI-DISPLAY (LED) indicating up to 6 temperatur...MICROPROCESSOR technology with PID temperature con...
SuperFreeze Peroxidase Conjugate Stabilizer from Pierce Biotechnology, Inc.
SA-HRP Dilution Buffer, 1L from Pierce Biotechnology, Inc.
Biology Products: